Schedule 13D ownership disclosure
Corcept Therapeutics Inc
Security class unavailable · CUSIP: 218352102
Event date: 2016-11-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,956,002
- Percent of class
- 9.8700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-139736
- Form type
- SC 13D
- Filer
- CORCEPT THERAPEUTICS INC
- CIK
- CIK 1088856
- Filed
- Dec 15, 2016
- Reporting period
- Nov 28, 2016
- Description
- Schedule 13D beneficial ownership